AAUM (Average Assets Under Management) of ₹33.41 Cr for Apr-Jun 2026 is the combined figure across Direct and Regular plans — sourced from AMFI India's quarterly disclosure. Equity Holdings above shows only the stock portion from the latest portfolio filing.
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 77.7% | 77.6% | ▼ -0.1% |
| Healthcare Services | 21.6% | 21.2% | ▼ -0.4% |
| Healthcare Equipment & Supplies | 1.0% | 1.0% | ● 0.0% |
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 77.6% | 78.9% | ▲ +1.3% |
| Healthcare Services | 21.2% | 20.4% | ▼ -0.8% |
| Healthcare Equipment & Supplies | 1.0% | 1.0% | ● +0.0% |
Comparing Jul 2026 → Aug 2026
| # | Stock | Sector | Jul 2026 | Aug 2026 | Change |
|---|---|---|---|---|---|
| 1 | Aurobindo Pharma Limited ₹3.64 Cr |
Pharmaceuticals & Biotechnology | 6.66% | 7.16% | +0.50% |
| 2 | Glenmark Pharmaceuticals Limited ₹2.86 Cr |
Pharmaceuticals & Biotechnology | 5.13% | 5.63% | +0.50% |
| 3 | Neuland Laboratories Limited ₹1.52 Cr |
Pharmaceuticals & Biotechnology | 2.50% | 2.99% | +0.49% |
| 4 | Laurus Labs Limited ₹5.70 Cr |
Pharmaceuticals & Biotechnology | 10.77% | 11.23% | +0.46% |
| 5 | IPCA Laboratories Limited ₹2.10 Cr |
Pharmaceuticals & Biotechnology | 3.70% | 4.13% | +0.43% |
| 6 | Gland Pharma Limited ₹1.76 Cr |
Pharmaceuticals & Biotechnology | 3.04% | 3.46% | +0.42% |
| 7 | Sai Life Sciences Limited ₹1.54 Cr |
Pharmaceuticals & Biotechnology | 2.76% | 3.03% | +0.27% |
| 8 | GlaxoSmithKline Pharmaceuticals Limited ₹96.63 L |
Pharmaceuticals & Biotechnology | 1.67% | 1.90% | +0.23% |
| 9 | Piramal Pharma Limited ₹1.02 Cr |
Pharmaceuticals & Biotechnology | 1.85% | 2.01% | +0.16% |
| 10 | Global Health Limited ₹96.99 L |
Healthcare Services | 1.83% | 1.91% | +0.08% |
| # | Stock | Sector | Jul 2026 | Aug 2026 | Change |
|---|---|---|---|---|---|
| 1 | Lupin Limited ₹4.07 Cr |
Pharmaceuticals & Biotechnology | 8.94% | 8.01% | -0.93% |
| 2 | Alkem Laboratories Limited ₹2.39 Cr |
Pharmaceuticals & Biotechnology | 5.13% | 4.70% | -0.43% |
| 3 | Fortis Healthcare Limited ₹3.62 Cr |
Healthcare Services | 7.50% | 7.12% | -0.38% |
| 4 | Krishna Institute Of Medical Sciences Limited ₹1.50 Cr |
Healthcare Services | 3.18% | 2.95% | -0.23% |
| 5 | Biocon Limited ₹2.25 Cr |
Pharmaceuticals & Biotechnology | 4.63% | 4.43% | -0.20% |
| 6 | Abbott India Limited ₹1.03 Cr |
Pharmaceuticals & Biotechnology | 2.21% | 2.03% | -0.18% |
| 7 | Mankind Pharma Limited ₹2.09 Cr |
Pharmaceuticals & Biotechnology | 4.26% | 4.11% | -0.15% |
| 8 | Narayana Hrudayalaya Limited ₹1.01 Cr |
Healthcare Services | 2.14% | 1.99% | -0.15% |
| 9 | Onesource Specialty Pharma Limited ₹91.43 L |
Pharmaceuticals & Biotechnology | 1.94% | 1.80% | -0.14% |
| 10 | Wockhardt Limited ₹1.19 Cr |
Pharmaceuticals & Biotechnology | 2.47% | 2.34% | -0.13% |
30 stocks — Aug 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹5.70 Cr |
Pharmaceuticals & Biotechnology |
11.23%
|
|
| 2 |
₹4.07 Cr |
Pharmaceuticals & Biotechnology |
8.01%
|
|
| 3 |
₹3.64 Cr |
Pharmaceuticals & Biotechnology |
7.16%
|
|
| 4 |
₹3.62 Cr |
Healthcare Services |
7.12%
|
|
| 5 |
₹2.86 Cr |
Pharmaceuticals & Biotechnology |
5.63%
|
|
| 6 |
₹2.39 Cr |
Pharmaceuticals & Biotechnology |
4.70%
|
|
| 7 |
₹2.25 Cr |
Pharmaceuticals & Biotechnology |
4.43%
|
|
| 8 |
₹2.10 Cr |
Pharmaceuticals & Biotechnology |
4.13%
|
|
| 9 |
₹2.09 Cr |
Pharmaceuticals & Biotechnology |
4.11%
|
|
| 10 |
₹1.76 Cr |
Pharmaceuticals & Biotechnology |
3.46%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.